Using a smartphone app to monitor Raynaud's Phenomenon
Development of an Application for the Monitoring and Evaluation of Raynaud's Phenomenon
This study is testing a smartphone app that helps people with Raynaud's Phenomenon track their symptoms to see if it can improve their understanding and management of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 120 (estimated) |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble Cedex 9, Grenoble) |
| Trial ID | NCT03984422 on ClinicalTrials.gov |
What this trial studies
This study evaluates the feasibility of a smartphone application designed for the monitoring and evaluation of Raynaud's Phenomenon. Participants will use the app to track their symptoms and experiences related to the condition. The goal is to determine how effectively the app can assist in managing and understanding this phenomenon. The study is observational, meaning it will collect data without altering participants' treatment plans.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with primary or secondary Raynaud's Phenomenon who have access to compatible smartphones.
Not a fit: Patients who do not speak or understand French or are under administrative or judicial supervision may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could provide patients with a convenient tool to better manage their Raynaud's Phenomenon.
How similar studies have performed: While the use of smartphone applications for monitoring health conditions is gaining traction, this specific approach for Raynaud's Phenomenon is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * primary or secondary Raynaud phenomenon clinically diagnosed by a physician * Phone compatible with the application (most Android smartphones) * Non-opposition of participation in the study * Affiliation to the social security scheme or beneficiary of such a scheme Exclusion Criteria: * Subject under administrative or judicial supervision * Subject not speaking and not understanding French
Where this trial is running
Grenoble Cedex 9, Grenoble
- Chu Grenoble Alpes — Grenoble Cedex 9, Grenoble, France (Recruiting)
Study contacts
- Principal investigator: Matthieu Roustit, PharmD, PhD — University Hospital, Grenoble
- Study coordinator: Matthieu Roustit, PharmD, PhD
- Email: mroustit@chu-grenoble.fr
- Phone: +33476767856
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.